• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化肝脏中肝细胞癌的肝切除术:肝功能受损时进行该手术是否不合理?

Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function?

作者信息

Wu C C, Ho W L, Yeh D C, Huang C R, Liu T J, P'eng F K

机构信息

Department of Surgery, Taichung Veterans General Hospital, Taiwan.

出版信息

Surgery. 1996 Jul;120(1):34-9. doi: 10.1016/s0039-6060(96)80238-8.

DOI:10.1016/s0039-6060(96)80238-8
PMID:8693420
Abstract

BACKGROUND

Resection for hepatocellular carcinoma in patients with cirrhosis and impaired liver function is usually unjustified because of higher surgical risks and poorer long-term prognosis.

METHODS

A retrospective comparison of the background and resectional results of patients with cirrhosis and hepatocellular carcinoma was carried out between those with preoperative indocyanine green 15-minute retention rate of 20% or greater (group A, impaired function group, n = 36) and those with indocyanine green 15-minute retention rate of 10% or less (group B, normal function group, n = 34).

RESULTS

The group A patients had significantly lower serum albumin level and higher serum bilirubin level, longer prothrombin time, higher incidence of associated esophageal varices, and poorer Child's classifications for cirrhosis. Although the tumor diameter in both groups was similar (A, 6.9 versus B, 7.1 cm; p = 0.94), the resected liver amount in group B was greater (227.4 versus 473.2 gm; p = 0.038) because of a greater extent of liver resection (p < 0.001) and a wider surgical margin (0.34 versus 1.85 cm; p < 0.0001). The amount of operative blood loss and blood transfusion, operative morbidity, and operative mortality were not different between the two groups. The pathologic characteristics and staging were also comparable. The 5-year disease-free and actuarial survival rates of groups A and B were 30.9% and 29.6% (p = 0.16) and 45.2% and 33.4% (p = 0.11), respectively.

CONCLUSIONS

If the amount of resected nontumorous liver parenchyma could be reduced, resection of hepatocellular carcinoma in selected patients with cirrhosis and impaired liver function is still justified in spite of a narrow surgical margin.

摘要

背景

由于手术风险较高且长期预后较差,通常不主张对肝硬化及肝功能受损的肝细胞癌患者进行手术切除。

方法

对术前吲哚菁绿15分钟潴留率为20%或更高的肝硬化合并肝细胞癌患者(A组,功能受损组,n = 36)和吲哚菁绿15分钟潴留率为10%或更低的患者(B组,功能正常组,n = 34)的背景和切除结果进行回顾性比较。

结果

A组患者血清白蛋白水平显著较低,血清胆红素水平较高,凝血酶原时间较长,合并食管静脉曲张的发生率较高,肝硬化的Child分级较差。尽管两组的肿瘤直径相似(A组为6.9 cm,B组为7.1 cm;p = 0.94),但B组切除的肝组织量更大(分别为227.4 g和473.2 g;p = 0.038),这是因为肝切除范围更大(p < 0.001)且手术切缘更宽(分别为0.34 cm和1.85 cm;p < 0.0001)。两组的术中失血量、输血量、手术并发症发生率和手术死亡率并无差异。病理特征和分期也具有可比性。A组和B组的5年无病生存率和实际生存率分别为30.9%和29.6%(p = 0.16)以及45.2%和33.4%(p = 0.11)。

结论

如果能够减少非肿瘤性肝实质的切除量,那么对于部分肝硬化及肝功能受损的肝细胞癌患者,尽管手术切缘较窄,进行手术切除仍是合理的。

相似文献

1
Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function?肝硬化肝脏中肝细胞癌的肝切除术:肝功能受损时进行该手术是否不合理?
Surgery. 1996 Jul;120(1):34-9. doi: 10.1016/s0039-6060(96)80238-8.
2
Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.严重肝硬化肝脏的肝细胞癌肝切除术
Hepatogastroenterology. 2003 Mar-Apr;50(50):491-6.
3
Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?对于Child-Pugh C级肝硬化患者的肝细胞癌,肝切除术是否绝对禁忌?
Hepatogastroenterology. 1999 Mar-Apr;46(26):635-9.
4
Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.肝硬化患者大肝细胞癌切除是否有益?38例研究。
Hepatogastroenterology. 2001 May-Jun;48(39):757-61.
5
Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients.肝硬化患者肝细胞癌的保守性肝切除术
Int Surg. 1996 Jul-Sep;81(3):280-3.
6
Is liver resection for hepatocellular carcinoma in cirrhotic patients with high preoperative serum alanine aminotransferase level unadvisable?对于术前血清丙氨酸氨基转移酶水平较高的肝硬化肝细胞癌患者,进行肝切除术是否不可取?
Hepatogastroenterology. 2014 Oct;61(135):2068-76.
7
Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.小肝癌患者行肝段切除术或肝叶切除术:20 年经验回顾
Surgery. 2010 May;147(5):676-85. doi: 10.1016/j.surg.2009.10.043. Epub 2009 Dec 11.
8
Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.对合并肝硬化的肝细胞癌进行肝切除。
Hepatogastroenterology. 2002 Sep-Oct;49(47):1363-8.
9
Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.慢性乙型肝炎伴或不伴肝硬化患者肝切除术后肝细胞癌无病生存期的比较。
J Med Assoc Thai. 2015 Apr;98(4):334-42.
10
Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.直径大于或等于10厘米的肝细胞癌的肝切除术
Hepatogastroenterology. 2002 Mar-Apr;49(44):518-23.

引用本文的文献

1
Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.非侵入性纤维化标志物与肝癌肝切除术后术后死亡率的关系。
JAMA Netw Open. 2019 Jan 4;2(1):e187142. doi: 10.1001/jamanetworkopen.2018.7142.
2
ICG Clearance Test and 99mTc-GSA SPECT/CT Fusion Images.吲哚菁绿清除试验和99m锝-甘氨双乙酸盐单光子发射计算机断层扫描/计算机断层扫描融合图像
Visc Med. 2017 Dec;33(6):449-454. doi: 10.1159/000479046. Epub 2017 Nov 22.
3
Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).
中晚期肝细胞癌的外科治疗:第五届亚太原发性肝癌专家会议(APPLE 2014)共识报告
Liver Cancer. 2016 Oct;5(4):245-256. doi: 10.1159/000449336. Epub 2016 Sep 14.
4
Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis.用(99m)Tc-GSA单光子发射计算机断层扫描测量肝清除率以评估肝纤维化。
World J Gastroenterol. 2014 Nov 28;20(44):16714-20. doi: 10.3748/wjg.v20.i44.16714.
5
Liver tissue sparing resection using a novel planning tool.利用新型规划工具进行肝组织保留性切除术。
Langenbecks Arch Surg. 2011 Feb;396(2):201-8. doi: 10.1007/s00423-010-0734-y. Epub 2010 Dec 16.
6
Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure.血浆吲哚菁绿清除率作为急性肝衰竭预后指标的灵敏度和特异性。
BMC Gastroenterol. 2009 Dec 3;9:91. doi: 10.1186/1471-230X-9-91.
7
HA/GSA-Rmax ratio as a predictor of postoperative liver failure.HA/GSA-Rmax比值作为术后肝衰竭的预测指标。
World J Surg. 2008 Nov;32(11):2410-8. doi: 10.1007/s00268-008-9725-3.
8
Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased?存在肝硬化或脂肪变性时的肝脏手术:发病率会增加吗?
Patient Saf Surg. 2008 Apr 25;2:8. doi: 10.1186/1754-9493-2-8.
9
Surgical treatment of hepatocellular carcinoma: evidence-based outcomes.肝细胞癌的外科治疗:基于证据的结果
World J Gastroenterol. 2008 Feb 7;14(5):685-92. doi: 10.3748/wjg.14.685.
10
The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vascular invasion.高血清睾酮水平对无血管侵犯的早期肝细胞癌男性患者肝切除术后长期预后的影响。
World J Surg. 2007 Jul;31(7):1469-73. doi: 10.1007/s00268-007-9094-3.